Sirsat 2010.

Methods	Study design: parallel RCT Study duration: not reported Duration of follow‐up: 1 year
Participants	Country: India Setting: not reported Inclusion criteria: adult kidney transplant recipients Number: 41 Mean age ± SD (years): not reported Sex (M/F): not reported Exclusion criteria: not reported
Interventions	Treatment group Pamidronate: 60 mg (IV) at baseline and 6 months post transplant Control group Alendronate: 70 mg/week for 1 year Co‐interventions Not reported
Outcomes	BMD
Notes	Abstract‐only publication Data cannot be meta‐analysed
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Insufficient information to permit judgement
Allocation concealment (selection bias)	Unclear risk	Insufficient information to permit judgement
Blinding of participants and personnel (performance bias) All outcomes	High risk	Open‐label study
Blinding of outcome assessment (detection bias) All outcomes	Unclear risk	Insufficient information to permit judgement
Incomplete outcome data (attrition bias) All outcomes	Unclear risk	Insufficient information to permit judgement
Selective reporting (reporting bias)	High risk	Data cannot be meta‐analysed, numbers per group not reported, no SD
Other bias	Unclear risk	Insufficient information to permit judgement